Related content

KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives

By  

Current Molecular Medicine, Vol. 15, Iss. 5, 2015-06 ,pp. : 418-432

Bentham Science Publishers

Access to resources Recommend Favorite

Over-Expression of Egfr is Closely Correlated to Poor Prognosis in Tunisian Patients with Non-Small Cell Lung Adenocarcinoma

By              

Journal of Immunoassay and Immunochemistry, Vol. 35, Iss. 3, 2014-07 ,pp. : 256-268

Taylor & Francis Ltd

Access to resources Recommend Favorite

Association of EGFR mutations with low BRCA1 gene expression in non-small cell lung cancer

By Li   Xie   Lai  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 195-199

Spandidos Publications

Access to resources Recommend Favorite

Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status

By                              

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 187-196

Spandidos Publications

Access to resources Recommend Favorite

ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer

By  

The Journal Of Pathology: Clinical Research, Vol. 1, Iss. 3, 2015-06 ,pp. : 134-143

John Wiley & Sons Inc

Access to resources Recommend Favorite